Pharmaceuticals News and Research

RSS

Isis Pharmaceuticals receives $3 million milestone payment from GSK

Isis Pharmaceuticals, Inc. announced today that it has earned a $3.0 million milestone payment from GlaxoSmithKline (GSK) related to the initiation of a natural history study, which will support the advancement of one of the alliance programs.

15 May 2014

China Pharma Holdings' revenue decreases 14% to $7.1 million in first quarter 2014

China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced its financial results for the three months ended March 31, 2014.

15 May 2014

University of Missouri to award honorary degree to Chairman and CEO of Synergy Pharmaceuticals

Synergy Pharmaceuticals Inc., today announced its Chairman and Chief Executive Officer, Dr. Gary S. Jacob, will be recognized and awarded with the honorary degree, Doctor of Science Honoris Causa, from his alma mater, the University of Missouri - St. Louis, at a commencement ceremony this Saturday, May 17, 2014.

15 May 2014

APCER Pharma's MD to teach global medical affairs strategy workshop at World Congress Summit

APCER Pharma, the truly global provider of outsourced services for clinical safety, pharmacovigilance, medical affairs, and regulatory operations, announced that the company's Managing Director, Dr. Vineet Kacker, will be one of the leaders in a workshop on developing a successful global Medical Affairs strategy.

15 May 2014

Prestige Brands’ net revenues decrease $144.3M to 6.6% in Q4 and FY 2014

Prestige Brands Holdings, Inc. ("the Company") today announced results for the fourth quarter and the fiscal year ended March 31, 2014.

15 May 2014

Virtualscopics reports record revenues in first quarter 2014

VirtualScopics, Inc., a leading provider of quantitative imaging solutions, today reported the financial results for the first quarter ended March 31, 2014.

15 May 2014

Rep. Jan Schakowsky visits Wockhardt plant, commends production expansion in Illinois

Rep. Jan Schakowsky visited Wockhardt's Morton Grove facility with a goal in mind: strengthening efforts to revitalize American manufacturing.

15 May 2014

OxThera granted new patents for treatment of hyperoxaluria

OxThera AB announced today that it has been granted two new US patents and one new Australian patent during the last year.

15 May 2014

Viewpoints: Access to abortion in Virginia; patient habits and health costs; 'little states that couldn't'

As a candidate last year, Virginia Gov. Terry McAuliffe (D) promised to do what he could to roll back absurd, baldly political rules imposed on the state's abortion clinics with the transparent purpose of forcing many of them to close.

15 May 2014

Retrophin reports net loss of $70.6 million for first quarter 2014

Retrophin, Inc. today reported its financial results for the quarter ended March 31, 2014.

14 May 2014

Isis Pharmaceuticals reports positive data from ISIS-GCGRRx Phase 2 study in patients with type 2 diabetes

Isis Pharmaceuticals, Inc. announced today positive data from a Phase 2 study of ISIS-GCGRRx in patients with type 2 diabetes uncontrolled on stable metformin therapy.

14 May 2014

Viewpoints: What's next for employer mandate; SCOTUS and retiree health plans; the 'next big issue'

As complaints and cavils about the Affordable Care Act fall by the wayside, one piece of the law looms ever larger as its most controversial element: the employer mandate, which in 2016 will impose a penalty on businesses with 50 to 99 employees for not offering them health coverage (Michael Hiltzik, 5/12).

14 May 2014

Protein Data Bank now contains over 100,000 structures

Spanning the globe from the US, UK, and Japan, the Worldwide Protein Data Bank (wwPDB) organization announces that the Protein Data Bank archive now contains more than 100,000 entries.

14 May 2014

Researchers develop chip-like device to sort, store and retrieve individual living cells for study

A U.S. and Korean research team has developed a chip-like device that could be scaled up to sort and store hundreds of thousands of individual living cells in a matter of minutes. The system is similar to a random access memory chip, but it moves cells rather than electrons.

14 May 2014

Eagle Pharmaceuticals total revenue increases by $2.5 million for Q2 2014

Eagle Pharmaceuticals, Inc. today announced its financial results for the three-month period ended March 31, 2014. This marks the first period for which Eagle is reporting financial results as a public company.

14 May 2014

USC/NYU researchers develop small molecule that interferes with cancer progression with minimal side effects

A team of researchers from USC and NYU has developed and patented a small molecule that interferes with cancer progression with minimal side effects.

14 May 2014

Ajinomoto announces Phase 2a results of oral alpha 4 integrin antagonist AJM300 in ulcerative colitis patients

Ajinomoto Pharmaceuticals Co., Ltd. (President, Takashi Nagamachi; Headquarters, Tokyo, Japan) announced on May 13 that the Phase 2a results of an oral alpha 4 integrin antagonist, AJM300, in patients with ulcerative colitis were presented in the Joint Presidential Plenary Session at Digestive Disease Week (DDW) 2014 held May 3 - 6 in Chicago, IL, USA.

13 May 2014

Study: Katrina and Rita hurricanes may be responsible for stillbirths in worst hit areas

Hurricanes Katrina and Rita may be responsible for up to half of the stillbirths in the areas hardest hit by the storms, according to a new study co-authored by Ian Breunig, PhD, a postdoctoral fellow in the Department of Pharmaceutical Health Services Research (PHSR) and the Center for Innovative Pharmacy Solutions in the Department of Pharmacy Practice and Science (PPS) at the University of Maryland School of Pharmacy.

13 May 2014

Da Volterra presents promising results of DAV-132 compound for prevention of severe C. diff infections

Da Volterra, a leading biopharmaceutical company in the field of bacterial resistance, announces today very promising new results about DAV132 in the prevention of the side effects of antibiotics and the occurrence of severe Clostridium difficile infections.

13 May 2014

Perrigo receives final approval from FDA for azelastine hydrochloride nasal spray ANDA

Perrigo Company plc announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%).

12 May 2014

Pharmaceuticals News and Research

Isis Pharmaceuticals receives $3 million milestone payment from GSK

China Pharma Holdings' revenue decreases 14% to $7.1 million in first quarter 2014

University of Missouri to award honorary degree to Chairman and CEO of Synergy Pharmaceuticals

APCER Pharma's MD to teach global medical affairs strategy workshop at World Congress Summit

Prestige Brands’ net revenues decrease $144.3M to 6.6% in Q4 and FY 2014

Virtualscopics reports record revenues in first quarter 2014

Rep. Jan Schakowsky visits Wockhardt plant, commends production expansion in Illinois

OxThera granted new patents for treatment of hyperoxaluria

Viewpoints: Access to abortion in Virginia; patient habits and health costs; 'little states that couldn't'

Retrophin reports net loss of $70.6 million for first quarter 2014

Isis Pharmaceuticals reports positive data from ISIS-GCGRRx Phase 2 study in patients with type 2 diabetes

Viewpoints: What's next for employer mandate; SCOTUS and retiree health plans; the 'next big issue'

Protein Data Bank now contains over 100,000 structures

Researchers develop chip-like device to sort, store and retrieve individual living cells for study

Eagle Pharmaceuticals total revenue increases by $2.5 million for Q2 2014

USC/NYU researchers develop small molecule that interferes with cancer progression with minimal side effects

Ajinomoto announces Phase 2a results of oral alpha 4 integrin antagonist AJM300 in ulcerative colitis patients

Study: Katrina and Rita hurricanes may be responsible for stillbirths in worst hit areas

Da Volterra presents promising results of DAV-132 compound for prevention of severe C. diff infections

Perrigo receives final approval from FDA for azelastine hydrochloride nasal spray ANDA

Pittcon Highlights: Pharmaceutical & Biologic eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence